-
Most Popular
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring
Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock.
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.
DNA Stock Alert: Ginkgo Bioworks Moves Forward With Novo Nordisk Partnership
Ginkgo Bioworks (DNA) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk.
Why Is Better Therapeutics (BTTX) Stock Up 39% Today?
Better Therapeutics (BTTX) stock is taking off on Tuesday as investors react to approval from the FDA for a Type 2 diabetes treatment.
Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?
CytoMed Therapeutics (GDTC) stock is rocketing higher on Tuesday despite a lack of news concerning the company this morning.
BIIB Stock Alert: What to Know as FDA Approves Biogen’s Alzheimer’s Drug
Biogen (BIIB) stock is in the news Friday after the pharmaceutical company got approval from the FDA for its Alzheimer's drug.
The $25 Million Reason Caribou Biosciences (CRBU) Stock Is Soaring Today
Caribou Biosciences (CRBU) stock is taking off on Thursday after the gene-editing company announced an investment from Pfizer (PFE).
Why Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today?
Nymox Pharmaceutical (NYMX) stock is falling on Thursday after the company told investors its shares will be delisted tomorrow.
Why Is VBI Vaccines (VBIV) Stock Down 40% Today?
VBI Vaccines (VBIV) stock is taking a beating on Thursday after the pharmaceutical company announced two stock offerings.
Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results
Cassava Sciences (SAVA) stock is down 11% on underwhelming results from its clinical trials for its Alzheimer's treatment.
Why Is Allarity Therapeutics (ALLR) Stock Up 30% Today?
Allarity Therapeutics became the toast of Wall Street Wednesday with positive early clinical data, though ALLR stock remains risky.